Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes

Circulation: Heart Failure

Volumn 4, Issue 3, 2011, Pages 276-285

  Lewis, Gregory D ^a   Murphy, Ryan M ^a   Shah, Ravi V ^a   Pappagianopoulos, Paul P ^a   Malhotra, Rajeev ^a   Bloch, Kenneth D ^a   Systrom, David M ^a   Semigran, Marc J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Exercise; Heart failure; Hypertension; Pulmonary

Indexed keywords

PLACEBO; SILDENAFIL;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; HEART LEFT VENTRICLE; HEMODYNAMIC MONITORING; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; SYSTOLIC DYSFUNCTION; VENOUS OXYGEN TENSION; AGED; EXERCISE TEST; EXERCISE TOLERANCE; HEART LEFT VENTRICLE FUNCTION; LUNG CIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; PULMONARY ARTERY; PULMONARY VEIN; SYSTOLE;

AGED; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY ARTERY; PULMONARY CIRCULATION; PULMONARY VEINS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79960570365     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.110.959437     Document Type: Article

References (50)

1. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37: 183-188. (Pubitemid 32051736)
2. Costard-Jackle A, Fowler MB. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 1992;19:48-54.
3. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol. 1999;34: 1802-1806.
4. Lewis GD, Gona P, Larson MG, Plehn JF, Benjamin EJ, O'Donnell CJ, Levy D, Vasan RS, Wang TJ. Exercise blood pressure and the risk of incident cardiovascular disease (from the Framingham Heart Study). Am J Cardiol. 2008;101:1614-1620.
5. Mundal R, Kjeldsen SE, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Exercise blood pressure predicts mortality from myocardial infarction. Hypertension. 1996;27:324-329. (Pubitemid 26082074)
6. Osada N, Chaitman BR, Miller LW, Yip D, Cishek MB, Wolford TL, Donohue TJ. Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol. 1998;31: 577-582. (Pubitemid 28144124)
7. Singh JP, Larson MG, Manolio TA, O'Donnell CJ, Lauer M, Evans JC, Levy D. Blood pressure response during treadmill testing as a risk factor for new-onset hypertension. The Framingham heart study. Circulation. 1999;99:1831-1836. (Pubitemid 29181411)
8. Benbassat J, Froom P. Blood pressure response to exercise as a predictor of hypertension. Arch Intern Med. 1986;146:2053-2055. (Pubitemid 16006701)
9. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009;34:888-894.
10. Reeves JT, Moon RE, Grover RF, Groves BM. Increased wedge pressure facilitates decreased lung vascular resistance during upright exercise. Chest. 1988;93:97S-99S. (Pubitemid 18075476)
11. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation. 2008;118:2183-2189.
12. Meyer B, Mortl D, Strecker K, Hulsmann M, Kulemann V, Neunteufl T, Pacher R, Berger R. Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol. 2005;46:1011-1018. (Pubitemid 41316508)
13. Fang ZY, Marwick TH. Vascular dysfunction and heart failure: epiphenomenon or etiologic agent? Am Heart J. 2002;143:383-390. (Pubitemid 34185167)
14. Giannattasio C, Achilli F, Grappiolo A, Failla M, Meles E, Gentile G, Calchera I, Capra A, Baglivo J, Vincenzi A, Sala L, Mancia G. Radial artery flow-mediated dilatation in heart failure patients: effects of pharmacological and nonpharmacological treatment. Hypertension. 2001;38: 1451-1455. (Pubitemid 34033432)
15. Mancini D, Katz S, Donchez L, Aaronson K. Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with heart failure. Circulation. 1996;94:2492-2496. (Pubitemid 26403578)
16. Metra M, Faggiano P, D'Aloia A, Nodari S, Gualeni A, Raccagni D, Dei Cas L. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol. 1999;33:943-950.
17. Gandevia B, Hugh-Jones P. Terminology for measurements of ventilatory capacity; a report to the thoracic society. Thorax. 1957;12:290-293.
18. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis. 1984;129:S49-S55. (Pubitemid 14190983)
19. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation. 2007;116:1555-1562. (Pubitemid 47511419)
20. Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME, Systrom DM, Bloch KD, Semigran MJ. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation. 2007;115:59-66. (Pubitemid 46058612)
21. Wasserman K, Hansen JE, Sue DY, Stringer W, Whipp BJ, eds. Principles of Exercise Testing and Interpretation, 4 ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
22. Morimont P, Lambermont B, Ghuysen A, Gerard P, Kolh P, Lancellotti P, Tchana-Sato V, Desaive T, D'Orio V. Effective arterial elastance as an index of pulmonary vascular load. Am J Physiol Heart Circ Physiol. 2008;294:H2736-H2742.
23. Wasserman K, Whipp BJ. Exercise physiology in health and disease. Am Rev Respir Dis. 1975;112:219-249.
24. Gibbs JS, Cunningham D, Shapiro LM, Park A, Poole-Wilson PA, Fox KM. Diurnal variation of pulmonary artery pressure in chronic heart failure. Br Heart J. 1989;62:30-35. (Pubitemid 19171233)
25. Degre S, de Coster A, Messin R, Denolin H. Normal pulmonary pressure-flow relationship during exercise in the sitting position. Int Z Angew Physiol. 1972;31:53-59.
26. Bevegard S, Holmgren A, Jonsson B. The effect of body position on the circulation at rest and during exercise, with special reference to the influence on the stroke volume. Acta Physiol Scand. 1960;49: 279-298.
27. West JB, Dollery CT, Naimark A. Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures. J Appl Physiol. 1964; 19:713-724.
28. Ekelund LG. Circulatory and respiratory adaptation during prolonged exercise of moderate intensity in the sitting position. Acta Physiol Scand. 1967;69:327-340.
29. Moraes DL, Colucci WS, Givertz MM. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation. 2000;102:1718-1723.
30. Katz SD, Khan T, Zeballos GA, Mathew L, Potharlanka P, Knecht M, Whelan J. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure. Circulation. 1999;99: 2113-2117. (Pubitemid 29196794)
31. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, Volterrani M, Bonetti P, Parrinello G, Cadei M, Grigolato PG, Ferrari R. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation. 1999;100: 1983-1991. (Pubitemid 29529291)
32. Arimura K, Egashira K, Nakamura R, Ide T, Tsutsui H, Shimokawa H, Takeshita A. Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure. Am J Physiol Heart Circ Physiol. 2001;280:H68-H75.
33. Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998;12:773-790. (Pubitemid 28294668)
34. Agostoni PG, Bussotti M, Palermo P, Guazzi M. Does lung diffusion impairment affect exercise capacity in patients with heart failure? Heart. 2002;88:453-459. (Pubitemid 35221951)
35. Perego GB, Marenzi GC, Guazzi M, Sganzerla P, Assanelli E, Palermo P, Conconi B, Lauri G, Agostoni PG. Contribution of PO2, P50, and Hb to changes in arteriovenous O2 content during exercise in heart failure. J Appl Physiol. 1996;80:623-631.
36. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol. 2005;98:390-403. (Pubitemid 40041273)
37. Hambraeus-Jonzon K, Bindslev L, Mellgard AJ, Hedenstierna G. Hypoxic pulmonary vasoconstriction in human lungs. A stimulusresponse study. Anesthesiology. 1997;86:308-315. (Pubitemid 27093375)
38. Randhawa PS, Chopra P, Tandon HD. Autopsy study of pulmonary vascular changes in patients of rheumatic mitral stenosis. Indian J Med Res. 1983;78:681-688.
39. Tumminello G, Lancellotti P, Lempereur M, D'Orio V, Pierard LA. Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure. Eur Heart J. 2007;28:569-574. (Pubitemid 47355524)
40. Verhaert D, Mullens W, Borowski A, Popovic ZB, Curtin RJ, Thomas JD, Tang WH. Right ventricular response to intensive medical therapy in advanced decompensated heart failure. Circ Heart Fail. 2010;3: 340-346.
41. Riopel DA, Taylor AB, Hohn AR. Blood pressure, heart rate, pressure-rate product and electrocardiographic changes in healthy children during treadmill exercise. Am J Cardiol. 1979;44: 697-704. (Pubitemid 10246980)
42. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol. 1995;25:1143-1153.
43. Abel FL, Waldhausen JA. Effects of alterations in pulmonary vascular resistance on right ventricular function. J Thorac Cardiovasc Surg. 1967; 54:886-894.
44. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977-2016.
45. Lepore JJ, Maroo A, Bigatello LM, Dec GW, Zapol WM, Bloch KD, Semigran MJ. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest. 2005;127:1647-1653. (Pubitemid 46218790)
46. Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol. 2007;50:2136-2144. (Pubitemid 350117342)
47. Behling A, Rohde LE, Colombo FC, Goldraich LA, Stein R, Clausell N. Effects of 5-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. J Card Fail. 2008;14:189-197. (Pubitemid 351444866)
48. Guazzi M, Vicenzi M, Arena R, Guazzi MD. PDE5-inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry and clinical status in patients with stable systolic heart failure: results of a 1-year prospective, randomized, placebo-controlled study. Circ Heart Fail. 2011;4:8-17.
49. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346: 1845-1853. (Pubitemid 34603028)
50. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-2694. (Pubitemid 37430139)